Guinea starts testing Merck vaccine in Ebola hotspots
March 25, 2015 at 10:57 AM EDT
CONAKRY/DAKAR, March 25 (Reuters) - Guinea started testing an experimental Ebola vaccine from Merck and NewLink Genetics on affected communities this week, in a move officials hope will accelerate the end of an epidemic first detected a year ago.
